Literature DB >> 15573859

Recommendations for the diagnosis and management of osteoporosis.

Abdullah Alkhenizan.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15573859      PMCID: PMC6148145          DOI: 10.5144/0256-4947.2004.396

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


× No keyword cloud information.
To the Editor: I read with interest the recommendations for the diagnosis and management of osteoporosis by Hussein Raef et al published in the July/August 2004 issue. I have several concerns about the methodology used in the synthesis of these recommendations. First, the authors did not provide any systematic method for searching the literature, which makes these recommendations prone to bias in the selection of included studies. In addition, the authors did not provide any description of included and excluded studies. Second, there is no linkage of the recommendations to their level of evidence. This issue is a key feature of high quality Clinical Practice Guidelines (CPGs), as recommendations that are based on expert opinion are not as valid as recommendations based on level 1 evidence.1 It has been shown that when health care providers accept and follow CPGs, they have the potential to improve both the process of care and patient health outcomes.2,3 However, concerns about the quality of guidelines might limit their acceptance and application by health care providers.4 The cost and resources needed for the development of CPGs is huge and few practices have the resources and skills to develop valid high quality guidelines.5 The overall cost can be considerably reduced if guideline developers “locally adapt” high quality guidelines as a basis for producing their own guideline. There is a growing recognition that national guideline developers do not need to duplicate efforts and waste resources in the development of CPGs. Several developed countries (e.g., New Zealand, Germany and Iceland) encourage local adaptation of international good quality guidelines to avoid duplication of work and cost involved in guidelines development. Local adaptation of CPGs addresses local clinical issues and circumstances and gives a sense of ownership of the clinical guidelines. The Guideline International Network (GIN) suggested a comprehensive methodology for the local adaptation of clinical guidelines.6 There are several high quality osteoporosis guidelines that follow high methodological standards available in the literature.7,8 If the authors tried to “locally adapt” these high quality guidelines they would save significant time and resources, and they would produce a much more useful guidelines for practitioners in Saudi Arabia. This is not limited to osteoporosis guidelines; wherever possible, all Saudi guideline developers should work on the local adaptation of existing good quality guidelines.
  5 in total

1.  Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children.

Authors:  M C Steinhoff; M K Abd el Khalek; N Khallaf; H S Hamza; A el Ayadi; A Orabi; H Fouad; M Kamel
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

2.  Residents find clinical practice guidelines valuable as educational and clinical tools.

Authors:  A Helwig; D Bower; M Wolff; C Guse
Journal:  Fam Med       Date:  1998-06       Impact factor: 1.756

3.  Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination.

Authors:  S H Woolf; R N Battista; G M Anderson; A G Logan; E Wang
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

4.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors:  J M Grimshaw; I T Russell
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

Review 5.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.